Table 2.
Fixed combination latanoprost/timolol, n (%) | Unfixed combination brimonidine/timolol, n (%) | |
Total randomised | 166 (100.0) | 168 (100.0) |
Completed study | 156 (94.0) | 139 (82.7) |
Withdrew from study | 10 (6.0) | 29 (17.3) |
Reasons for withdrawal | ||
Adverse event | 3 (1.8) | 18 (10.7) |
Uncontrolled IOP | 3 (1.8) | 3 (1.8) |
Protocol violation | 3 (1.8) | 2 (1.2) |
Consent withdrawn | 0 (0.0) | 5 (3.0) |
Lost to follow up | 1 (0.6) | 0 (0.0) |
Other | 0 (0.0) | 1 (0.6) |
IOP, intraocular pressure.